BAILARD, INC. - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,507,000
-28.9%
111,000
-15.3%
0.05%
-34.2%
Q1 2021$2,120,000
-54.0%
131,000
-24.3%
0.08%
-62.4%
Q4 2020$4,604,000
+42.9%
173,0000.0%0.21%
+25.7%
Q3 2020$3,221,000
-27.9%
173,000
-9.4%
0.17%
-33.2%
Q2 2020$4,469,000
+428.9%
191,000
+31.7%
0.25%
+316.7%
Q1 2020$845,000145,0000.06%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders